BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 37458617)

  • 1.
    Liu Z; Jia X; Wu P; Wu B; Pan Y; Zhong S; Xiao L; Song Y; Hu J; Zhou K
    Pharmacogenomics; 2023 Jul; 24(10):551-560. PubMed ID: 37458617
    [No Abstract]   [Full Text] [Related]  

  • 2. Variation in the Plasma Membrane Monoamine Transporter (PMAT) (Encoded by
    Dawed AY; Zhou K; van Leeuwen N; Mahajan A; Robertson N; Koivula R; Elders PJM; Rauh SP; Jones AG; Holl RW; Stingl JC; Franks PW; McCarthy MI; 't Hart LM; Pearson ER;
    Diabetes Care; 2019 Jun; 42(6):1027-1033. PubMed ID: 30885951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of plasma membrane monoamine transporter genetic variants on pharmacokinetics of metformin in humans.
    Moon SJ; Oh J; Lee SH; Choi Y; Yu KS; Chung JY
    Transl Clin Pharmacol; 2018 Jun; 26(2):79-85. PubMed ID: 32055553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Serotonin Transporter 5-HTTLPR Polymorphism on Gastrointestinal Intolerance to Metformin: A GoDARTS Study.
    Dujic T; Zhou K; Tavendale R; Palmer CN; Pearson ER
    Diabetes Care; 2016 Nov; 39(11):1896-1901. PubMed ID: 27493135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organic cation transporter 1 variants and gastrointestinal side effects of metformin in patients with Type 2 diabetes.
    Dujic T; Causevic A; Bego T; Malenica M; Velija-Asimi Z; Pearson ER; Semiz S
    Diabet Med; 2016 Apr; 33(4):511-4. PubMed ID: 26605869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding and overcoming metformin gastrointestinal intolerance.
    Bonnet F; Scheen A
    Diabetes Obes Metab; 2017 Apr; 19(4):473-481. PubMed ID: 27987248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the phenotype of patients with gastrointestinal intolerance to metformin?
    Hermans MP; Ahn SA; Rousseau MF
    Diabetes Metab; 2013 Sep; 39(4):322-9. PubMed ID: 23786968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of genetic variation in the organic cation transporters OCT1, OCT2 and multidrug and toxin extrusion 1 transporter protein genes with the gastrointestinal side effects and lower BMI in metformin-treated type 2 diabetes patients.
    Tarasova L; Kalnina I; Geldnere K; Bumbure A; Ritenberga R; Nikitina-Zake L; Fridmanis D; Vaivade I; Pirags V; Klovins J
    Pharmacogenet Genomics; 2012 Sep; 22(9):659-66. PubMed ID: 22735389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin treatment and gastrointestinal symptoms in youth: Findings from a large tertiary care referral center.
    Meyers AG; Hudson J; Cravalho CKL; Matta ST; Villalobos-Perez A; Cogen F; Chung ST
    Pediatr Diabetes; 2021 Mar; 22(2):182-191. PubMed ID: 33179823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of body mass index or dosage on gastrointestinal disorders associated with extended-release metformin in type 2 diabetes: Sub-analysis of a Phase IV open-label trial in Chinese patients.
    Guo L; Guo X; Li Y; Hong X; Jiang X; Su Q; Zhao D; Wu X; Ji L
    Diabetes Metab Syndr; 2016; 10(3):137-42. PubMed ID: 26948203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of metformin-induced gastrointestinal symptoms on quality of life and adherence in patients with type 2 diabetes.
    Florez H; Luo J; Castillo-Florez S; Mitsi G; Hanna J; Tamariz L; Palacio A; Nagendran S; Hagan M
    Postgrad Med; 2010 Mar; 122(2):112-20. PubMed ID: 20203462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the Reduced Function Met420del Polymorphism of SLC22A1 with Metformin-Induced Gastrointestinal Intolerance in Ethiopian Patients with Type 2 Diabetes Mellitus.
    Degaga A; Sirgu S; Huri HZ; Sim MS; Loganadan NK; Kebede T; Tegene B; Engidawork E; Shibeshi W
    Pharmgenomics Pers Med; 2024; 17():183-191. PubMed ID: 38715682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between organic cation transporter genetic polymorphisms and metformin response and intolerance in T2DM individuals: a systematic review and meta-analysis.
    Peng A; Gong C; Xu Y; Liang X; Chen X; Hong W; Yan J
    Front Public Health; 2023; 11():1183879. PubMed ID: 37546319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of clinical and pharmacogenetic factors influencing metformin response in Type 2 diabetes mellitus.
    Pérez-Gómez N; Fernández-Ortega MD; Elizari-Roncal M; Santos-Mazo E; la Maza-Pereg L; Calvo S; Alcaraz R; Sanz-Solas A; Vinuesa R; Saiz-Rodríguez M
    Pharmacogenomics; 2023 Aug; 24(12):651-663. PubMed ID: 37610884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Organic Cation Transporter 1 With Intolerance to Metformin in Type 2 Diabetes: A GoDARTS Study.
    Dujic T; Zhou K; Donnelly LA; Tavendale R; Palmer CN; Pearson ER
    Diabetes; 2015 May; 64(5):1786-93. PubMed ID: 25510240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of metformin in patients with gastrointestinal intolerance.
    McCreight LJ; Stage TB; Connelly P; Lonergan M; Nielsen F; Prehn C; Adamski J; Brøsen K; Pearson ER
    Diabetes Obes Metab; 2018 Jul; 20(7):1593-1601. PubMed ID: 29457876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered Glycemic Control Associated With Polymorphisms in the SLC22A1 (OCT1) Gene in a Mexican Population With Type 2 Diabetes Mellitus Treated With Metformin: A Cohort Study.
    Reséndiz-Abarca CA; Flores-Alfaro E; Suárez-Sánchez F; Cruz M; Valladares-Salgado A; Del Carmen Alarcón-Romero L; Vázquez-Moreno MA; Wacher-Rodarte NA; Gómez-Zamudio JH
    J Clin Pharmacol; 2019 Oct; 59(10):1384-1390. PubMed ID: 31012983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota of patients with type 2 diabetes and gastrointestinal intolerance to metformin differs in composition and functionality from tolerant patients.
    Díaz-Perdigones CM; Muñoz-Garach A; Álvarez-Bermúdez MD; Moreno-Indias I; Tinahones FJ
    Biomed Pharmacother; 2022 Jan; 145():112448. PubMed ID: 34844104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetic variation and metformin response.
    Chen S; Zhou J; Xi M; Jia Y; Wong Y; Zhao J; Ding L; Zhang J; Wen A
    Curr Drug Metab; 2013 Dec; 14(10):1070-82. PubMed ID: 24329113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin.
    Zhou K; Yee SW; Seiser EL; van Leeuwen N; Tavendale R; Bennett AJ; Groves CJ; Coleman RL; van der Heijden AA; Beulens JW; de Keyser CE; Zaharenko L; Rotroff DM; Out M; Jablonski KA; Chen L; Javorský M; Židzik J; Levin AM; Williams LK; Dujic T; Semiz S; Kubo M; Chien HC; Maeda S; Witte JS; Wu L; Tkáč I; Kooy A; van Schaik RHN; Stehouwer CDA; Logie L; ; ; ; Sutherland C; Klovins J; Pirags V; Hofman A; Stricker BH; Motsinger-Reif AA; Wagner MJ; Innocenti F; 't Hart LM; Holman RR; McCarthy MI; Hedderson MM; Palmer CNA; Florez JC; Giacomini KM; Pearson ER
    Nat Genet; 2016 Sep; 48(9):1055-1059. PubMed ID: 27500523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.